Related Experiment Video
Updated: Jun 17, 2025

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
The SEER Program's longstanding commitment to making cancer resources available
Patricia K Murphy1, Mark E Sellers1, Sarah H Bonds1
1Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
The Surveillance, Epidemiology, and End Results (SEER) Program provides vital US cancer statistics and resources. It serves diverse audiences including researchers and the public, enhancing cancer research and awareness.
Area of Science:
- Oncology
- Public Health
- Biostatistics
Background:
- The Surveillance, Epidemiology, and End Results (SEER) Program, funded by the National Cancer Institute (NCI) since 1973, is a primary source for US cancer statistics.
- SEER aims to measure the national cancer burden, disseminate findings, and support cancer research initiatives.
Purpose of the Study:
- To outline the SEER Program's objectives and the diverse resources it offers to various user groups.
- To highlight SEER's commitment to accessibility, user experience, and continuous resource updates in line with legislative mandates.
Main Methods:
- The SEER Program collects and analyzes cancer data across the United States.
- Resources are developed and maintained for specific audiences: cancer registrars, researchers, and the general public.
Main Results:
- SEER provides specialized resources like SEER*Rx, SEER*DMS, SEER*Stat, and linked databases (e.g., SEER-Medicare).
- Public-facing materials include Cancer Stat Facts sheets, SEER*Explorer, and educational video series.
- Resources are updated to comply with legislation like the Plain Writing Act and 21st Century Integrated Digital Experience Act (IDEA).
Conclusions:
- The SEER Program's dedication to providing accessible and understandable cancer data is crucial for research, public health, and informed decision-making.
- Ongoing efforts focus on promoting SEER resources, ensuring broad accessibility, and standardizing the dissemination of new information.
More Related Videos
10:51Preparation and Metabolic Assay of 3-dimensional Spheroid Co-cultures of Pancreatic Cancer Cells and Fibroblasts
Published on: August 23, 2017
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Survival Analysis